News & Updates

Acute sinusitis in kids: Bacterial testing may curb antibiotic use
Acute sinusitis in kids: Bacterial testing may curb antibiotic use
23 Aug 2023
Prior vaccinations may have AD risk-lowering benefit
Prior vaccinations may have AD risk-lowering benefit
22 Aug 2023
SC on par with IV rituximab in CD20+ diffuse large B-cell lymphoma
SC on par with IV rituximab in CD20+ diffuse large B-cell lymphoma
22 Aug 2023 byStephen Padilla

In patients with previously untreated CD20+ diffuse large B-cell lymphoma (DLBCL), treatment with subcutaneous (SC) rituximab is not inferior to intravenous (IV) rituximab in terms of serum trough levels, efficacy, and tolerability, as shown in a study presented at EHA 2023.

SC on par with IV rituximab in CD20+ diffuse large B-cell lymphoma
22 Aug 2023